SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS) -- Ignore unavailable to you. Want to Upgrade?


To: agent99 who wrote (739)9/10/1999 1:11:00 PM
From: Thomas Kelly  Read Replies (2) | Respond to of 849
 
Greetings, thread. I just got in at 3 5/8. No doubt there will be a pause while investors take profits and reflect on the fact that it is still only a preliminary research finding. However, once the potential impact hits home and people realise they may not be able to get in this low ever again, this thing will probably take off again. That's what I'm counting on. Does anyone have any insight into the quality of management?

Tom



To: agent99 who wrote (739)9/10/1999 9:51:00 PM
From: John McDonald  Read Replies (1) | Respond to of 849
 
I am greatly comforted by the fact that Matritech's basic technology has proven to be solid. NMPS just needs a blockbuster product like the breast cancer test to make us a lot of money.



To: agent99 who wrote (739)9/11/1999 6:30:00 PM
From: D. Chapman  Respond to of 849
 
NMPS ..the company did not mention which proteins were present in elevated levels.

The company officials should be cited for fraud and the stock will be at lower levels within a week.